Flecainide Therapy
Flecainide Therapy is a pharmacological treatment modality classified under antiarrhythmic therapy that employs the class Ic sodium channel blocker flecainide acetamide to suppress cardiac arrhythmias by selectively inhibiting myocardial fast sodium channels and thereby reducing conduction velocity in atrial and ventricular tissues.
550
Publications
33.4K
Citations
2.2K
Authors
698
Institutions
Publications per year
2017–2026
48
Parents
550
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
Hiroshi Watanabe, Nagesh Chopra, Derek R. Laver et al. · Nature Medicine · 2009 · 600 citations · Full text
Medicine, Cardiology, Pharmacology +12
1–5 of 550
2.2K
14
h-index
11
h-index
11
h-index
10
h-index
9
h-index
1–5 of 2.2K
698

Vanderbilt University
Nashville, United States
14 h-index
68 publications
9.5K citations

St Bartholomew's Hospital
London, United Kingdom
13 h-index
69 publications
3.6K citations

University of Bologna
Bologna, Italy
10 h-index
49 publications
5.3K citations
University of Utah
Salt Lake City, United States
10 h-index
25 publications
3.1K citations

Amsterdam UMC Location University of Amsterdam
Amsterdam, The Netherlands
9 h-index
27 publications
5.4K citations

Montreal Heart Institute
Montreal, Canada
9 h-index
32 publications
3.4K citations

University of Groningen
Groningen, The Netherlands
8 h-index
23 publications
2.1K citations
Harvard University
Cambridge, United States
8 h-index
24 publications
652 citations
1–8 of 698
72 publications · 5.2K citations
42
h-index
JACC · 25 publications · 2K citations
24
h-index
19 publications · 3.3K citations
19
h-index
PACE · 20 publications · 673 citations
17
h-index
17 publications · 957 citations
16
h-index
1–5